Sun M. Thuret R. Abdollah F. et al.

Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.

Eur Urol. 2011; 59: 135-141View in Article Scopus (239) PubMed Abstract Full Text Full Text PDF Google ScholarIsrael G.M. Bosniak M.A.

Renal imaging for diagnosis and staging of renal cell carcinoma.

Urol Clin North Am. 2003; 30: 499-514View in Article Scopus (0) PubMed Abstract Full Text Full Text PDF Google ScholarKane C.J. Mallin K. Ritchey J. et al.

Renal cell cancer stage migration: analysis of the National Cancer Data Base.

Cancer. 2008; 113: 78-83View in Article Scopus (464) PubMed Crossref Google ScholarMir M.C. Capitanio U. Bertolo R. et al.

Role of active surveillance for localized small renal masses.

Eur Urol Oncol. 2018; 1: 177-187View in Article Scopus (63) PubMed Abstract Full Text Full Text PDF Google ScholarBechtold R.E. Zagoria R.J.

Imaging approach to staging of renal cell carcinoma.

Urol Clin North Am. 1997; 24: 507-522View in Article Scopus (0) PubMed Abstract Full Text Full Text PDF Google ScholarJohnson D.C. Vukina J. Smith A.B. et al.

Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate.

J Urol. 2015; 193: 30-35View in Article PubMed Crossref Google ScholarLee H. Lee J.K. Kim K. et al.

Risk of metastasis for T1a renal cell carcinoma.

World J Urol. 2016; 34: 553-559View in Article Scopus (26) PubMed Crossref Google ScholarLjungberg B. Bensalah K. Canfield S. et al.

EAU guidelines on renal cell carcinoma: 2014 update.

Eur Urol. 2015; 67: 913-924View in Article Scopus (1810) PubMed Abstract Full Text Full Text PDF Google ScholarLeibovich B.C. Blute M.L. Cheville J.C. et al.

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Cancer. 2003; 97: 1663-1671View in Article Scopus (587) PubMed Crossref Google ScholarDabestani S. Beisland C. Stewart G.D. et al.

Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.

Scand J Urol. 2019; 53: 14-20View in Article Scopus (13) Crossref Google ScholarLipsky M.J. Shapiro E.Y. Hruby G.W. et al.

Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma.

Urology. 2013; 81: 1190-1195View in Article PubMed Abstract Full Text Full Text PDF Google ScholarCimadamore A. Gasparrini S. Massari F. et al.

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy.

Cancers. 2019; 11https://doi.org/10.3390/cancers11020196View in Article Scopus (18) Crossref Google ScholarBergerot P.G. Hahn A.W. Bergerot C.D. et al.

The Role of Circulating Tumor DNA in Renal Cell Carcinoma.

Curr Treat Options Oncol. 2018; 19: 10View in Article Scopus (27) Crossref Google ScholarLianos G.D. Alexiou G.A. Mangano A. et al.

The role of heat shock proteins in cancer.

Cancer Lett. 2015; 360: 114-118View in Article PubMed Crossref Google ScholarVidyasagar A. Wilson N.A. Djamali A.

Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target.

Fibrogenesis Tissue Repair. 2012; 5: 7View in Article Scopus (175) PubMed Crossref Google ScholarWhite N.M.A. Masui O. Desouza L.V. et al.

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.

Oncotarget. 2014; 5: 506-518View in Article Scopus (77) Crossref Google ScholarFischer K. Theil G. Hoda R. et al.

Serum amyloid A: a biomarker for renal cancer.

Anticancer Res. 2012; 32: 1801-1804View in Article Google ScholarRamankulov A. Lein M. Johannsen M. et al.

Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.

Cancer Lett. 2008; 269: 85-92View in Article Scopus (43) PubMed Crossref Google ScholarVermaat J.S. Gerritse F.L. van der Veldt A.A. et al.

Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.

Eur Urol. 2012; 62: 685-695View in Article Scopus (0) Abstract Full Text Full Text PDF Google ScholarLannergård A. Larsson A. Kragsbjerg P. et al.

Correlations between serum amyloid A protein and C-reactive protein in infectious diseases.

Scand J Clin Lab Invest. 2003; 63: 267-272View in Article Crossref Google ScholarMiyata Y. Iwata T. Ohba K. et al.

Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.

Clin Cancer Res. 2006; 12: 6998-7003View in Article Scopus (70) Crossref Google ScholarLu H. Yang Z. Zhang H. et al.

The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.

Exp Ther Med. 2013; 5: 890-896View in Article Scopus (22) Crossref Google ScholarRamankulov A. Lein M. Johannsen M. et al.

Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.

Cancer Sci. 2008; 99: 1188-1194View in Article Scopus (0) PubMed Crossref Google ScholarBandopadhyay M. Bulbule A. Butti R. et al.

Osteopontin as a therapeutic target for cancer.

Expert Opin Ther Targets. 2014; 18: 883-895View in Article Scopus (94) PubMed Crossref Google ScholarSim S.H. Messenger M.P. Gregory W.M. et al.

Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.

Br J Cancer. 2012; 107: 1131-1137View in Article Scopus (44) Crossref Google ScholarPapworth K. Bergh A. Grankvist K. et al.

Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.

Acta Oncol. 2013; 52: 159-165View in Article Scopus (7) Crossref Google ScholarRamankulov A. Lein M. Kristiansen G. et al.

Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.

J Cancer Res Clin Oncol. 2007; 133: 643-652View in Article Scopus (49) Crossref Google ScholarRamchandani D. Weber G.F.

Interactions between osteopontin and vascular endothelial growth factor: Implications for cancer.

Biochim Biophys Acta. 2015; 1855: 202-222View in Article Google ScholarAhmed M. Behera R. Chakraborty G. et al.

Osteopontin: a potentially important therapeutic target in cancer.

Expert Opin Ther Targets. 2011; 15: 1113-1126View in Article Scopus (60) Crossref Google ScholarVerkman A.S.

More than just water channels: unexpected cellular roles of aquaporins.

J Cell Sci. 2005; 118: 3225-3232View in Article Scopus (493) PubMed Crossref Google ScholarGrebe S.K. Erickson L.A.

Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin?.

Mayo Clin Proc. 2010; 85: 410-412View in Article Scopus (0) PubMed Abstract Full Text Full Text PDF Google ScholarMorrissey J.J. Kharasch E.D.

The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.

J Urol. 2013; 189: 1913-1920View in Article Scopus (0) PubMed Crossref Google ScholarMorrissey J.J. London A.N. Luo J. et al.

Urinary biomarkers for the early diagnosis of kidney cancer.

Mayo Clin Proc. 2010; 85: 413-421View in Article Scopus (0) PubMed Abstract